HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5-((7-Chloro-6-fluoro-1h-indol-3-yl) methyl)-3-methylimidazolidine-2,4-dione as a RIP1 inhibitor protects LPS/D-galactosamine-induced liver failure.

AbstractAIMS:
Necroptosis, an inflammatory form of regulated necrosis mediated by receptor-interacting kinase 1 (RIP1), RIP3, and pseudokinase mixed lineage kinase domain-like protein (MLKL) is extensively implicated in liver inflammatory disease. Thus identification small-molecule inhibitor of necroptosis has emerged as a potential therapeutic strategy to prevent liver damage. In this study, we identified 5-((7-chloro-6-fluoro-1 h-indol-3-yl) methyl)-3-methylimidazolidine-2,4-dione (F-nec) as a novel potent necroptosis inhibitor.
MAIN METHODS:
To find out the potent chemical inhibitors of necroptosis, human monocytic U937 cells were treated with a combination of tumor necrosis factor alpha (TNFα) and a pan-caspase inhibitor z-VAD-fmk. LPS and D-galactosamine (LPS/GalN) were further employed to simulate acute liver failure to explore therapeutic potency of F-nec in vivo. In addition, a specific inhibitor of c-Jun NH (2)-terminal kinases (JNK) SP600125 and its activator anisomycin are used to elucidate its mechanisms in acute liver failure therapy. Necroptosis pathway related proteins were tested by western blot.
KEY FINDINGS:
In this study, we identified F-nec as a novel potent RIP1 inhibitor which efficiently blocked TNFα-induced necroptosis in human and mice cells. Furthermore, pre-treatment of F-nec could prevent hepatic necrosis by reducing RIP1-mediated necroptosis also effectively ameliorated LPS/GalN induced acute liver failure by attenuating cell death signaling-stimulated JNK pathway activation and then suppressing JNK-triggered inflammation.
SIGNIFICANCE:
Altogether, this study demonstrates that F-nec is a potent inhibitor of RIP1 and highlights its great potential for use in the treatment of RIP1-driven inflammatory liver diseases.
AuthorsAichun Li, Qin Yang, Guohua Lou, Yanning Liu, Hongguang Xia, Zhi Chen
JournalLife sciences (Life Sci) Vol. 273 Pg. 119304 (May 15 2021) ISSN: 1879-0631 [Electronic] Netherlands
PMID33662432 (Publication Type: Journal Article)
CopyrightCopyright © 2021. Published by Elsevier Inc.
Chemical References
  • GTPase-Activating Proteins
  • Indoles
  • Lipopolysaccharides
  • Protective Agents
  • Ralbp1 protein, mouse
  • Reactive Oxygen Species
  • Galactosamine
Topics
  • Animals
  • GTPase-Activating Proteins (antagonists & inhibitors)
  • Galactosamine (toxicity)
  • Humans
  • Indoles (chemistry)
  • Lipopolysaccharides (toxicity)
  • Liver Failure, Acute (chemically induced, drug therapy, metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Necroptosis
  • Protective Agents (pharmacology)
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction
  • U937 Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: